Taiwan Food and Drug Administration (TFDA) works with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host 9th Joint Conference of Taiwan and Japan on Medical Products Regulation on October 14th, 2021.
Since the “Framework of the Cooperation on the Medical Products Regulation” was signed by Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, both sides host Annual Joint Conference in alternative turns for nine years. This year, the representatives from TFDA, MHLW and PMDA share the latest information of medical products regulations, as well as other important topics such as COVID-19 measures, orphan drugs regulation, implementation for new medical devices regulation and emerging topics of medical devices, such as Unique Device Identification (UDI) regulation and Next Generation Sequencing (NGS) topic. Due to the impact of pandemic, this year’s conference is conducted as a webinar. Apart from the TFDA and MHLW and PMDA, around 500 participants from industries join the conference. The deliverables of this conference include reaching and enhancing the mutual understandings of the regulatory information and the collaborations between regulatory authority and industries.